Nobivac Tricat Trio, Lyophilisate and Solvent for Suspension for Injection for Cats
Nobivac Tricat Trio, Lyophilisate and Solvent for Suspension for Injection for Cats
Authorised
- Feline panleucopenia virus, strain MW-1, Live
- Feline rhinotracheitis virus, strain G2620A, Live
- Feline calicivirus, strain F9, Live
Product identification
Medicine name:
Nobivac Tricat Trio, Lyophilisate and Solvent for Suspension for Injection for Cats
Nobivac Tricat Trio Pellets en oplosmiddel voor suspensie voor injectie
Nobivac Tricat Trio Granulés médicamenteux et solvant pour suspension injectable
Nobivac Tricat Trio Wirkstoffhaltiges Pellet und Lösungsmittel zur Herstelling einer Injektionssuspension
Active substance:
- Feline panleucopenia virus, strain MW-1, Live
- Feline rhinotracheitis virus, strain G2620A, Live
- Feline calicivirus, strain F9, Live
Target species:
-
Cat
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Feline panleucopenia virus, strain MW-1, Live0.63tissue culture infective dose 501.00Dose
-
Feline rhinotracheitis virus, strain G2620A, Live0.72plaque forming unit1.00Dose
-
Feline calicivirus, strain F9, Live0.66plaque forming unit1.00Dose
Pharmaceutical form:
-
Lyophilisate and solvent for suspension for injection
Withdrawal period by route of administration:
-
Subcutaneous use
- Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI06AD04
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Belgium
Package description:
- (ID4) 50 Dose; 50 millilitre(s): Box (Cardboard) with 50 Box (Cardboard) each with 1 Bottle (Glass) with 1 Dose and 1 Bottle (Glass) with 1 millilitre(s)
- (ID2) 10 millilitre(s); 10 Dose: Box (Cardboard) with 10 Box (Cardboard) each with 1 Bottle (Glass) with 1 Dose and 1 Bottle (Glass) with 1 millilitre(s)
- (ID1) 5 Dose; 5 millilitre(s): Box (Cardboard) with 5 Box (Cardboard) each with 1 Bottle (Glass) with 1 Dose and 1 Bottle (Glass) with 1 millilitre(s)
- (ID3) 25 millilitre(s); 25 Dose: Box (Cardboard) with 25 Box (Cardboard) each with 1 Bottle (Glass) with 1 Dose and 1 Bottle (Glass) with 1 millilitre(s)
- (ID5) 5 Dose; 5 millilitre(s): Box (plastic) with 5 Box (plastic) each with 1 Bottle (Glass) with 1 Dose and 1 Bottle (Glass) with 1 millilitre(s)
- (ID6) 10 millilitre(s); 10 Dose: Box (plastic) with 10 Box (plastic) each with 1 Bottle (Glass) with 1 Dose and 1 Bottle (Glass) with 1 millilitre(s)
- (ID7) 25 millilitre(s); 25 Dose: Box (plastic) with 25 Box (plastic) each with 1 Bottle (Glass) with 1 Dose and 1 Bottle (Glass) with 1 millilitre(s)
- (ID8) 50 Dose; 50 millilitre(s): Box (plastic) with 50 Box (plastic) each with 1 Bottle (Glass) with 1 Dose and 1 Bottle (Glass) with 1 millilitre(s)
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
- Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- INTERVET INTERNATIONAL B.V.
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
- BE-V296895
Date of authorisation status change:
Reference member state:
-
Germany
Procedure number:
- DE/V/0240/001
Concerned member states:
-
Austria
-
Belgium
-
Bulgaria
-
Cyprus
-
Czechia
-
Denmark
-
Estonia
-
Finland
-
France
-
Greece
-
Hungary
-
Ireland
-
Italy
-
Latvia
-
Lithuania
-
Luxembourg
-
Netherlands
-
Norway
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Slovenia
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.
Labelling
This document does not exist in this language (English). You can find it in another language below.
How useful was this page?: